EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Digital application for drug product potency target evaluation in biopharmaceutical manufacturing

Darrick Shen, Shyam Panjwani iD, Konstantinos Spetsieris

Biotechnology Progress · 2024

DOI: 10.1002/btpr.3461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Progress, 2024. Verfasst von Darrick Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bayer Pharmaceuticals, Berkeley, California, USA. Hauptthemen laut MEDLINE: Biological Products, Software. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biopharmaceutical manufacturing entails a series of highly regulated steps. The manufacturing of safe and efficacious drug product (DP) requires testing of critical quality attributes (CQAs) against specification limits. DP potency concentration, which measures the dosage strength of a particular DP, is a CQA of great interest. In order to minimize the DP potency out‐of‐specification (OOS) risk, sterile fill finish (SFF) process adjustments may be needed. Varying the potency targets can be one such process adjustment. To facilitate such evaluation, data acquisition and statistical calculations are required. Regularly conducting the OOS risk assessment manually using commercial statistical software can be tedious, error‐prone, and impractical, especially when several alternate potency targets are under consideration. In this work, the development of a novel framework for OOS risk assessment and deployment of cloud‐based statistical software application to facilitate the risk assessment are presented. This application is intended to streamline the assessment of alternate potency targets for DP in biologics manufacturing. The major aspects of this potency targeting application development are presented in detail. Specifically, data sources, pipeline, application architecture, back‐end and front‐end development as well as application verification are discussed. Finally, several use cases are presented to highlight the application's utility in biologics manufacturing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsSoftwareRisk AssessmentQuality ControlHumans

Stichwörter der Autor:innen

Monte Carlo simulationbiologics manufacturing processout‐of‐specification (OOS) riskpotencysoftware application developmentstatistical modelingsterile fill finish

Substanzen

Biological Products

Autor:innen und Institutionen

  • Bayer Pharmaceuticals, Berkeley, California, USA.

ORCID-Profile: Shyam Panjwani

Zitieren

APA

Shen, D., Panjwani, S., & Spetsieris, K. (2024). Digital application for drug product potency target evaluation in biopharmaceutical manufacturing. Biotechnology Progress. https://doi.org/10.1002/btpr.3461

Vancouver

Shen D, Panjwani S, Spetsieris K. Digital application for drug product potency target evaluation in biopharmaceutical manufacturing. Biotechnology Progress. 2024. doi:10.1002/btpr.3461

BibTeX
@article{Shen2024,
  author = {Shen, Darrick and Panjwani, Shyam and Spetsieris, Konstantinos},
  title = {Digital application for drug product potency target evaluation in biopharmaceutical manufacturing},
  journal = {Biotechnology Progress},
  year = {2024},
  doi = {10.1002/btpr.3461}
}
Kostenlos starten →